Case-Based Peer Perspectives: A 61-Year-Old Woman with Metastatic Cholangiocarcinoma

Expert oncologist Milind Javle, MD, reflects on the optimal diagnosis and management of metastatic cholangiocarcinoma in the context of a hypothetical patient case.

EP. 1: Case Review: A 61-Year-Old Woman With Metastatic Cholangiocarcinoma

November 15th 2021

Expert oncologist Milind Javle, MD, reviews the diagnosis and treatment of intrahepatic cholangiocarcinoma in a 61-year-old who presents with jaundice and changes in stool and urine color.

EP. 2: Diagnosing Cholangiocarcinoma: Challenges and Molecular Profiling

November 15th 2021

Dr Milind Javle discusses challenges that exist in the early identification of cholangiocarcinoma, as well as the benefits of comprehensive molecular profiling.

EP. 3: Treatment Options for Metastatic Cholangiocarcinoma

November 15th 2021

Oncologist Dr. Milind Javel provides an overview of first- and subsequent-line treatments for patients with cholangiocarcinoma.

EP. 4: Metastatic Cholangiocarcinoma: Phase 2 Infigratinib Study and Personal Experience With Infigratinib

November 15th 2021

Milind Javle, MD, shares his personal experience and insights on the approval and use of infigratinib, an FGFR2 fusion–targeted therapy, in patients with previously treated advanced cholangiocarcinoma.

EP. 5: Recent Changes in the Cholangiocarcinoma Treatment Landscape

November 15th 2021

Dr Milind Javle discusses novel therapies recently approved or under investigation across multiple lines of therapy in patients with cholangiocarcinoma.

EP. 6: Key Takeaways for the Treatment of Cholangiocarcinoma

November 15th 2021

Concluding his reflection on novel therapies in patients with cholangiocarcinoma, Milind Javle, MD, provides closing thoughts and practical advice for his community colleagues.